Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 8/20 | 0.50 |
| ▸ | OPRM1 | P35372 | 7/20 | 0.50 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.50 |
| ▸ | CTSS | P25774 | 3/20 | 0.49 |
| ▸ | CTSL | P07711 | 3/20 | 0.49 |
| ▸ | CTSB | P07858 | 2/20 | 0.49 |
| ▸ | REN | P00797 | 1/20 | 0.46 |
| ▸ | CTSK | P43235 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24760657 | 1.00 | OPRD1 (0.50) | OPRD1OPRM1OPRK1CTSSCTSL | |
| SCHEMBL25475224 | 0.96 | CTSS (0.52) | OPRD1OPRM1OPRK1CTSSCTSL | |
| SCHEMBL25504002 | 0.94 | CTSS (0.50) | OPRD1OPRM1OPRK1CTSSCTSL | |
| SCHEMBL27376928 | 0.92 | OPRD1 (0.53) | OPRD1OPRM1OPRK1CTSSCTSL | |
| SCHEMBL24760229 | 0.91 | OPRM1 (0.48) | OPRD1OPRM1OPRK1CTSSCTSL | |
| SCHEMBL26559151 | 0.89 | OPRM1 (0.51) | OPRD1OPRM1OPRK1CTSSCTSL | |
| SCHEMBL24760306 | 0.89 | OPRD1 (0.53) | OPRD1OPRM1OPRK1CTSSCTSL | |
| SCHEMBL24774070 | 0.89 | OPRD1 (0.53) | OPRD1OPRM1OPRK1CTSSCTSL | |
| SCHEMBL24482587 | 0.89 | OPRM1 (0.50) | OPRD1OPRM1OPRK1CTSBREN | |
| SCHEMBL25475244 | 0.89 | OPRM1 (0.50) | OPRD1OPRM1OPRK1CTSBREN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023201234-A2 | ANTI-VARIABLE MUC1* ANTIBODIES AND USES THEREOF | MINERVA BIOTECHNOLOGIES CORPORATION (US) | 2023-10-19 | — | — | WO | disclosed |
| WO-2023078464-A1 | EPSILON-POLY-L-LYSINE-BASED DRUG CONJUGATE, INTERMEDIATE THEREOF, AND APPLICATION THEREOF | 上海弼领生物技术有限公司 | 2023-05-11 | — | — | WO | disclosed |
| WO-2022262789-A1 | ANTITUMOR COMPOUND AND USE THEREOF | 明慧医药（杭州）有限公司 | 2022-12-22 | — | — | WO | disclosed |